Loxifrit TH 8 Capsule containing Lornoxicam and Thiocolchicoside is used for the management of pain, inflammation, and muscle spasm-related conditions. It helps reduce discomfort and supports improved mobility in musculoskeletal disorders.
Lornoxicam works as a non-steroidal anti-inflammatory drug (NSAID) that helps reduce pain and inflammation, while Thiocolchicoside acts as a muscle relaxant that helps relieve muscle stiffness and spasms. Together, they provide comprehensive musculoskeletal support.
The capsule is widely prescribed in orthopedic, rheumatology, and general medicine practice for back pain, neck pain, joint disorders, muscle spasms, and other painful musculoskeletal conditions, leading to consistent prescription demand.
With increasing prevalence of musculoskeletal disorders and growing demand for combination pain management therapies, this product offers strong business potential for retailers and distributors. Its dual-action formulation, broad clinical relevance, and steady market demand make it a reliable product for growth in the pain management segment.